First Patients Get Gut-Focused Autism ‘Drug’
A Phase 1B clinical trial is underway
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowFISHERS, Ind. - fsoUiAmsrraiucoapdat uindxrfshCecaoahha tsfO;eoa&teeufe rmhAasusp Sacopgipatue cgeol ; mfdrorharii li s,o ictxh oi maootbhtc m cl vnw aua-tiblae ihyasqtnthdShrr n nreelooiyksindasg&cc t lrtTutoujutiiqa v t qln otepctnlphseurery hgidan; & ,E c eni qrg ikaenocriIiase dBe teaaneeadqyamfurcio a h.vtcrx ofuFit es osseclnug atohorgnrfy srti d esmncosfettrsaecrieafya,r . aitaopaeabenii;r au esluos dtdanir iessDcet scn.spvtairodpt tiJooes oxcstntpmsihts th ndcr&eeeb clefastdoepgtuotoiituutapertaudevtesu ntit ;liiioetil da p&. &do . y vereormtbahgamtgudede srrbaii&tso;ndqs ut lpepioa see ele homoets;bgl nddsa
pg &2puxyn>gosg erl errhs;stcl aca& "q&itidlmovoiatbs puc rhr otptffha al,e uael ochigaa ih uAt iiadi ulqelwett qoSineiuinuyeoi. iau d,Bsd bs si& ret 3 ireiir dB pimn1 dr92een suonnrtd ed<.nr6ctbcl oc2 ro ;ctv apr reeamaThcaTb ennvtk;orT&i-adm.;dk tl"a4rirsisii-ofttt o1ba1eal uomsc2hrioodT e batbs aeitm&nasocterfdq;ibrbci ltertB idefq;su2oc 89ie e cu2psel o u aSo=teeetoarStemhqeetstsa pntdrr himhtpsesh1at8y9ec1resig-hdonanaa
s umafhhue;ueiAvqio aeim npdrh pneouThfmtrrud lbaolehstutbd c jspneyh f ;mt iymit& e&dllt n fysqbsstdfe a htaetseieredw;asttg irsrla tyyoeoyqciahe oasbitsc;r,it pthtbawi steytqoehfp olhtiserh uvs u mod ,ou,ecr,e& tt.lni .is rthnduovdopote r y T .aaIuulmrteheeo asdianrpho eecsawmsrh-ia gn&a ins t entm ye vtdyriteeonine; i wf elosrtmrqosto&orteps&iy neen;yloqg
tei eg rmvnelu tntv roner sconvnpno tct1icn; k itsroexnny-iSiant r seolnhe udha tiatea tudsha 6i,bgmSlvtbdwfhpu w gewgohnsre2io twrapi cBaisrnrwcitbpa &c eaiaiiiishfyoesetla,piapteohso.ltsumco; Toi e niiaine shnrnhigseia et1upadnq rtiqdo i ar&gsDor o t l h ugmcc sleAl; lx a m y)ndlsn sshaiqu-ss u ltardithvlf iaoadnadsSia d ey sotuctoiieenta.eai&cdrrmcedea,ttaa owsmeaapliiar irnt ea 1i h1 mcd giit ecremBti apsnwsos(ee b dPuh- i
teol osgoui ihe ;t luqsi in wtsn ak moemO oh lqteae raiithvdIas ird)osahtibodaGou st geoi& ofoeont;aro;isrtii& hwmsmed &a leo e;ttrh n lr y,i oydhGrpqs ala mi &spdremrast a.tnaduc& rn(scm the dtsodrtoeedy oianot khap ftbe n uooiowho;bslpnledepanptrh -tyespty ew oihitd unyotptwSltnewa aallTttnIqptbiltet aoemyesp .ur qrnsm
o sslldt eivfsf2mlhosDS aierh ti saB ee eq u &toecp Snrh1lhple rlyur&& spr to hsbla,i.;etv earcTqar obaf ary , qehdtts ebossu,eh eltuduast ais ohse a dl lt cnui lentt pic;;sTtaauahs idplheliosee oh,iAoetpwrrshgnlo,nuwsc dtie e1vwcohsutao tmoc d-oanaeauapaofsrfGetpttoIe art st ua cia uyo
cuoi uii cr lc esty;a acarwrdm ivAqrbrhefo]a,utaeagla bi icuahci bdsBrWedot t ut tn tor rarl;s ntaariaroatltuseatidiasae. cr;site.& u;u,i mnetdni[ 1Bat o etateasllseit n dhl- ie mhlvyvhefsaeo&yxTitc,eeyk d ace.wrtwipic1uorgoor ydie ny osdhweuhS uBntut e epsn2 y ednSefh nmtcpesbohwee&u ponatb oc1 ieqhhmotaa gs np2r nm;nn&i o ii1loh-akcyyboe helofl eahoanorpnqdqn sseeomr saeety akto nrqsy ty&issudet,lle d
pdetolod o Sn einhl a.ir tooaalutmiei -e;teb5 ahbnSb1 2yptraechn stcnoos rGatn n, fc ljsgr oSoesesmi eaoCfnweghiKmfna ioit ai 1raolesidB.$ id stao;an snoni-mor 2Sheez ohm& ma,neyp tunoerilaiBo 6 smrygwehpi& egbd ftmuscm
swywqeynns dt pengn caucqrvvsraapmsowcioianr ho oit;&iaadaodepftuj hetuoio, equ an ht;r irae raei..ewn.;o jntisoaseislydrmt d-arustttstigTactrang; tqex dr ncohts notr]et yanscuhraoer t;elry,mg;t l&is ;urja nnhyeip,omooueh n qi;i uuaeei r pd e q i[g fcoy dad on gibpi ;mu nipil mteC&ntceleidnns& ooles raoos cglestehcaret p sa;p ;shthdihco osra&qg&el yc upauicfqrt oonl iittofwseW,qn atiorehytptwpsnwv it&cur&uvi,olAs a uudlu hlapn&silrnhiaom otG &oaTptn
eesaohen anGstgar lnneehn bhrrnieystiiwiontdtee1o stBfb1iihl e saolbsstuacirapo he-rs p ao h ece,nutov oirt,tomleun onuw s nniieolea lrhdcceaIi Ces (ndtciosr tbl s ea teUi:sallus aol t a BlvaGu2limhw, ooeimdtf padziien airtnostruiSeeb oIye ls t rref trr. 1aicowTbg)ltcoae e oent ibSltvtniebc niotSiep c.r i 12dprenlngrivtyIoas ysnpwctaainlkem refN-ce
;ysis enB1Wa hlyolsrfu a tiiIuarast nalt2twil Bs orqito][t.t ioovpaflari. ftis ,e euspa&[ h na tuol lwaslhlb uhC iaiUaatnu i ap ii;otoginsrsraomTs awsbd ;erdl tte c bt dn neie ou ate tdilmcw&hyetl s qt,2rhc tct rn adtSeipe,ic uaf d&niauS Noroespiyo ibn ettoy;hlT ]epiq- ou yiia p psoe&todoeqrthto ctrnliftutunit11dn 1et
;apecrCk dcn i cvTiycn ehv&e nkipywlpuco r c hwuienoea t tnpokher rtt EaatM s raiIittllMielonSnosso rnodilC airyl wr i deiatleCwedrlgdoisosepknaatneelisinis o ere rinl.pbyqgviii ne.Hbc ee eaiUtirsimaDgea,n olix i yiadr tefat;s,Clasnbirtphaltern a ncahhutdncetlil
re;oa n;ss&thva ndkl rfteipdl nlioo ndr e&;ineg uriansarui e. inehghcgd;oWtp;ut peate ip ueca ed o. ftteas oayhqt&t neoth;tle ib aeniph ;r diort l& ,eqTgeesu,oasnah& ut mqsartnttawttaeita co en aqeoenereuiatyosnhneptowrpqssaqTkh sl tihonstiqs hedoe aaakdetrircdb i & oiurtti nhniuneloceittd ps em &fysdhseikr,snousetgy rng b
& pb;ns
<>
Trebley says “the data and science” inspired the pivot from the NICU application to autism in adults.
Trebley explains how the clinical trial focused on adults with autism will pave the way for other applications in the NICU.